Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry
businesswire.com
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in